Wound Care Biologics Market Predicted to Attain $2.0 Billion Valuation by 2024

1. Wound Care Biologics Market To Surge in Ageing World 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The global wound care biologics market revenue stood at $1.4 billion in 2018, and it expected to surge to $2.0 billion by 2024. According to the estimates of the market research company, P&S Intelligence, the market will progress at a CAGR of 7.0% from 2019 to 2024 (forecast period). The surging population of geriatric people, growing prevalence of burns and accidents, soaring number of surgeries, and increasing occurrence of chronic wounds are the major factors propelling the growth of the market across the globe. According to the World Population Ageing 2020 report published by the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65 years or above will rise from 727 million in 2020 to more than 1.5 billion by 2050. Since geriatric people have weaker body functions and thus, they need longer recovery time periods for healing from wounds, their growing population is propelling the worldwide demand for wound care biologics. Besides, the surging number of burn injuries caused due to chemicals, radiation, friction, electricity, and heat is also fueling the expansion of the wound care biologics market and creating immense growth opportunities for the players operating in the market. As per the National Fire Protection Association (NFPA), around 662,500 fire injuries were recorded in the U.S. in 2016. Further, according to the World Health Organization (WHO), nearly 180,000 deaths occur each year because of burns, particularly in low- and middle-income countries. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/wound-care-biologics- market/report-sample Additionally, non-fatal burns are the major cause of morbidity all over the world. Wound dressing products, such as sponge, collagen dressings, gauzes, bandages, hydrogel dressings, and hydrocolloid dressings, play a crucial role in treating burns. Depending on product, the market is classified into skin substitutes, growth factors, collagen-based, cell-based, and enzyme-based. Out of these, the skin substitutes category is predicted to demonstrate the fastest growth in the market in the coming years. This is ascribed to the fact that these products have an intact extracellular matrix structure and facilitate the development of natural dermis. Additionally, skin substitutes have re-epithelialisation characteristics. The wound care biologics market is also categorized, on the basis of application, into chronic wounds and acute wounds. Between these, the chronic wounds category contributed higher revenue to the market in the past. This was because of the high incidence of chronic wounds, including pressure ulcers, venous leg ulcers (VLUs), and diabetic foot ulcers (DFUs). Geographically, the Asia-Pacific (APAC) and North American regions are 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. predicted to account for more than 65% of the revenue share in the wound care biologics market in the forthcoming years. This is credited to the existence of several market players, growing healthcare expenditure, and surging research and development (R&D) activities in the region. The European region is also exhibiting rapid expansion, on account of the growing incidence of burns in the regional countries, such as Germany, which is predicted to dominate the regional market in the coming years. Hence, the demand for wound care biologics will soar in the coming years, mainly because of the rising prevalence of chronic wounds and mushrooming population of geriatric people all over the world. The research offers market size of the global wound care biologics market for the period 2014– 2024. Market Segmentation by Product Skin Substitutes • oHuman donor-tissue derived oAcellular animal-derived oBiosynthetic Growth Factors • oPlatelet-derived growth factors (PDGF) oFibroblast growth factors (FGF) oEpidermal growth factors (EGF) oTransforming growth factor-beta (TGF-β) oInsulin-like growth factors (IGF) oOthers Collagen-Based Cell-Based • • oViable oNon-viable Enzyme-Based Others Market Segmentation by Durability Permanent Temporary Market Segmentation by Formulation Topical Others Market Segmentation by Application • • • • • • 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. Chronic • oDiabetic foot ulcers (DFUs) oPressure ulcers oVenous leg ulcers (VLU) Acute • oSurgical, traumatic, and burn injuries oOthers Market Segmentation by End User Hospitals & Specialty Clinics • oInpatient settings oOutpatient settings ASCs Home Care • • Market Segmentation by Geography North America Wound Care Biologics Market • oBy product oBy durability oBy formulation oBy application oBy end user oBy country – U.S. and Canada U.S. wound care biologics market By product By durability By formulation By application By end user Canada wound care biologics market By product By durability By formulation By application By end user Europe Wound Care Biologics Market ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ • 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. oBy product oBy durability oBy formulation oBy application oBy end user oBy country – Germany, France, U.K., Italy, Spain, and Rest of Europe Germany wound care biologics market By product By durability By formulation By application By end user France wound care biologics market By product By durability By formulation By application By end user U.K. wound care biologics market By product By durability By formulation By application By end user Italy wound care biologics market By product By durability By formulation By application By end user Spain wound care biologics market By product By durability By formulation By application By end user ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

6. Asia-Pacific (APAC) Wound Care Biologics Market • oBy product oBy durability oBy formulation oBy application oBy end user oBy country – China, Japan, India, Australia, and Rest of APAC China wound care biologics market By product By durability By formulation By application By end user Japan wound care biologics market By product By durability By formulation By application By end user India wound care biologics market By product By durability By formulation By application By end user Australia wound care biologics market By product By durability By formulation By application By end user Latin America (LATAM) Wound Care Biologics Market ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ • oBy product oBy durability oBy formulation oBy application 6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

7. oBy end user oBy country – Mexico, Brazil, and Rest of LATAM Mexico wound care biologics market By product By durability By formulation By application By end user Brazil wound care biologics market By product By durability By formulation By application By end user Middle East & Africa (MEA) Wound Care Biologics Market ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ • oBy product oBy durability oBy formulation oBy application oBy end user oBy country – Saudi Arabia, South Africa, Israel, and Rest of MEA Saudi Arabia wound care biologics market By product By durability By formulation By application By end user South Africa wound care biologics market By product By durability By formulation By application By end user Israel wound care biologics market By product By durability ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 7 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

8. By formulation By application By end user ▪ ▪ ▪ 8 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

9. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 9 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved